Skip to Main Content

Author Details

Qiulu Pan
Technical University of Munich
1999
30
16
PMIDPaper TitleJournal TitlePublished Year
35975488MiR-641 Exacerbates the Progression of Ischemic Stroke Through the MCL-1/Wnt/β-Catenin Pathway.Clin Lab2022
35670075Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties.J Enzyme Inhib Med Chem2022
33923231Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.J Pers Med2021
32045275Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.Arch Pathol Lab Med2020
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
23994118Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays.J Mol Diagn2013
22302699Dextrocardia, atrial septal defect, severe developmental delay, facial anomalies, and supernumerary ribs in a child with a complex unbalanced 8;22 translocation including partial 8p duplication.Am J Med Genet A2012
2762581417q12 Deletion in a patient with Williams syndrome: Case report and review of the literature.J Pediatr Genet2012
23198868Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas.Mol Cytogenet2012
21177903Evaluation of the 3M rapid detection test for respiratory syncytial virus (RSV) in children during the early stages of the 2009 RSV season.J Clin Microbiol2011
21416589Molecular characterization of an interstitial deletion of 1p31.3 in a patient with obesity and psychiatric illness and a review of the literature.Am J Med Genet A2011
21148747Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.Clin Cancer Res2011
20304809Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.Blood2010
20181819Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements.J Mol Diagn2010
17471158Validation of rapid polymerase chain reaction-based detection of all length polymorphisms in the UGT 1A1 gene promoter.Diagn Mol Pathol2007
17951211Comparative evaluation of three JAK2V617F mutation detection methods.Am J Clin Pathol2007
17525684Profound inhibition of the PCR step of CF V3 multiplex PCR/OLA assay by the use of UV-irradiated plastic reaction tubes.Diagn Mol Pathol2007
17721328CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s).Diagn Mol Pathol2007
17471160Validation of cystic fibrosis mutation analysis using ABI 3130XL genetic analyzer.Diagn Mol Pathol2007
16531770Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts.Diagn Mol Pathol2006
15696205KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.PLoS Med2005
15899142Epidermal growth factor receptor mutations detected in tumors from Chinese "never smokers" with lung adenocarcinoma.Chin Med J (Engl)2005
15920544EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.Mod Pathol2005
16049312Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.J Mol Diagn2005
14615382Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas.Blood2004
15029212Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.Leukemia2004
14669284Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood.Cancer2003
11243385Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay.Leukemia2001
10359862[Angiotensin 1-converting enzyme gene insertion/deletion polymorphism in patients with coronary artery disease and essential hypertension and its nucleotide sequence].Zhonghua Yi Xue Yi Chuan Xue Za Zhi1999
10450750Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia.Leukemia1999
  • 1 - 30 of 30

Recommended Authors

University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Washington University School of Medicine.
Career Start Year 2000
Number of shared co-authors 0
Qatar Foundation
Career Start Year 2000
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 1
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 0
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 0
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Ribeirao Preto Medical School - University of Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year 1991
Number of shared co-authors 0
CHU Sainte-Justine Research Center
Career Start Year 1991
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1988
Number of shared co-authors 0
The Ohio State University
Career Start Year 1988
Number of shared co-authors 9
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1987
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1987
Number of shared co-authors 3
Sainte-Justine University Hospital Research Center
Career Start Year 1986
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 4
David Geffen School of Medicine, university of california los angeles
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 4
Weill Cornell Medical College
Co-authored papers 2
Institute for Computational Biomedicine
Co-authored papers 2
New York NewYork-Presbyterian Hospital
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
University of Pittsburgh School of Medicine.
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
University of Bern
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Co-authored papers 1
Meyer Cancer Center
Co-authored papers 1
New York University Langone Health
Co-authored papers 1
Co-authored papers 1
New York-Presbyterian Hospital
Co-authored papers 1
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 1
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 1
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 1
Sandra and Edward Meyer Cancer Center
Co-authored papers 1
Case Western Reserve University
Co-authored papers 1
Weill Cornell Medical Center, NewYork Presbyterian Hospital
Co-authored papers 1
New York-Presbyterian Hospital-Weill Cornell Medical College
Co-authored papers 1
Sandra and Edward Meyer Cancer Center
Co-authored papers 1
Sandra and Edward Meyer Cancer Center
Co-authored papers 1
Co-authored papers 1
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 1
University of Trento
Co-authored papers 1
University Hospitals of Cleveland
Co-authored papers 1